Zevra Therapeutics, Inc. (ZVRA)
(Real Time Quote from BATS)
$6.43 USD
+0.20 (3.21%)
Updated Jul 16, 2024 12:22 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.47 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | 18.37% |
ABR | 1.00 |
Earnings ESP
|
-6.38% |
---|---|
Current Year | -1.57 |
Next Year | -0.20 |
EPS (TTM) | -1.35 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.19M | 5.42M | 27.91M | 105.76M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 4.65M | 5.56M | 37.91M | 131.75M |
Low Estimate | 3.90M | 5.19M | 22.61M | 86.63M |
Year ago Sales | 8.47M | 2.90M | 27.46M | 27.91M |
Year over Year Growth Est. | -50.50% | 86.76% | 1.64% | 278.94% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.47 | -0.45 | -1.57 | -0.20 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.50 | -0.48 | -1.64 | 0.29 |
High Estimate | -0.45 | -0.42 | -1.33 | 0.29 |
Low Estimate | -0.50 | -0.48 | -1.68 | -0.63 |
Year ago EPS | -0.15 | -0.40 | -1.30 | -1.57 |
Year over Year Growth Est. | -213.33% | -12.50% | -20.77% | 87.31% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 2 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.47 | -0.45 | -1.57 | -0.20 |
7 Days Ago | -0.45 | -0.44 | -1.55 | -0.13 |
30 Days Ago | -0.45 | -0.44 | -1.55 | -0.13 |
60 Days Ago | -0.45 | -0.43 | -1.54 | -0.13 |
90 Days Ago | -0.45 | -0.45 | -1.65 | -0.18 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.48 | -1.64 | 0.29 |
Zacks Consensus Estimate | -0.47 | -0.45 | -1.57 | -0.20 |
Earnings ESP | -6.38% | -7.46% | -4.63% | 247.46% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -0.40 | -0.40 | -0.15 | NA |
Estimate | -0.49 | -0.20 | -0.29 | -0.39 | NA |
Difference | 0.09 | -0.20 | -0.11 | 0.24 | 0.01 |
Surprise | 18.37% | -100.00% | -37.93% | 61.54% | -14.51% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more